1. Home
  2. RVMDW vs OXLCO Comparison

RVMDW vs OXLCO Comparison

Compare RVMDW & OXLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMDW
  • OXLCO
  • Stock Information
  • Founded
  • RVMDW N/A
  • OXLCO N/A
  • Country
  • RVMDW United States
  • OXLCO United States
  • Employees
  • RVMDW 490
  • OXLCO N/A
  • Industry
  • RVMDW
  • OXLCO Investment Managers
  • Sector
  • RVMDW
  • OXLCO Finance
  • Exchange
  • RVMDW Nasdaq
  • OXLCO Nasdaq
  • Market Cap
  • RVMDW N/A
  • OXLCO N/A
  • IPO Year
  • RVMDW N/A
  • OXLCO N/A
  • Fundamental
  • Price
  • RVMDW $0.15
  • OXLCO $23.05
  • Analyst Decision
  • RVMDW
  • OXLCO
  • Analyst Count
  • RVMDW 0
  • OXLCO 0
  • Target Price
  • RVMDW N/A
  • OXLCO N/A
  • AVG Volume (30 Days)
  • RVMDW N/A
  • OXLCO N/A
  • Earning Date
  • RVMDW N/A
  • OXLCO N/A
  • Dividend Yield
  • RVMDW N/A
  • OXLCO N/A
  • EPS Growth
  • RVMDW N/A
  • OXLCO N/A
  • EPS
  • RVMDW N/A
  • OXLCO N/A
  • Revenue
  • RVMDW N/A
  • OXLCO N/A
  • Revenue This Year
  • RVMDW N/A
  • OXLCO N/A
  • Revenue Next Year
  • RVMDW N/A
  • OXLCO N/A
  • P/E Ratio
  • RVMDW N/A
  • OXLCO N/A
  • Revenue Growth
  • RVMDW N/A
  • OXLCO N/A
  • 52 Week Low
  • RVMDW N/A
  • OXLCO N/A
  • 52 Week High
  • RVMDW N/A
  • OXLCO N/A
  • Technical
  • Relative Strength Index (RSI)
  • RVMDW N/A
  • OXLCO 59.90
  • Support Level
  • RVMDW N/A
  • OXLCO $22.97
  • Resistance Level
  • RVMDW N/A
  • OXLCO $23.10
  • Average True Range (ATR)
  • RVMDW 0.00
  • OXLCO 0.05
  • MACD
  • RVMDW 0.00
  • OXLCO 0.01
  • Stochastic Oscillator
  • RVMDW 0.00
  • OXLCO 88.09

About RVMDW Revolution Medicines Inc. Warrant

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About OXLCO Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

Share on Social Networks: